Golden House Ltd

Golden House maintains a strong liquidity position with ILS 81.77M in cash and equivalents, supporting a current ratio of 1.16. The company's price-to-book ratio of 57.31 and price-to-tangible-book ratio of 57.31 indicate a premium valuation relative to its equity base. However, the price-to-earnings ratio of 2,135.21 and EV/EBITDA of 1,110.29 suggest a high valuation multiple relative to earnings and cash flow generation. Profitability metrics show a return on equity of 2.68% and return on assets of 1.78%, both below the industry median for healthcare facilities. Operating income of ILS 13.96M and net income of ILS 7.27M represent 28.6% and 14.9% of revenue, respectively, indicating moderate margin performance. Gross profit of ILS 20.91M (42.8% of revenue) suggests cost control is a key operational strength. The company's geographic exposure is concentrated in Israel, with real estate investments in Germany, Spain, and the Czech Republic. No segment-specific revenue breakdown is available, but the primary business remains in Israel. The real estate investments may provide diversification but also introduce exposure to foreign market risks. Outlook for the current fiscal year shows a revenue of ILS 48.85M, with no specific growth guidance provided. Historical revenue trends are not available for comparison. The company's free cash flow of -ILS 192.20M indicates significant capital outflows, primarily driven by capital expenditures of -ILS 5.25M. This suggests the company is investing in growth or asset maintenance, though the negative free cash flow raises questions about long-term sustainability without external financing. Risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The debt-to-equity ratio of 0.24 suggests a conservative capital structure. However, the high valuation multiples and negative free cash flow could increase financial risk if earnings or cash flow performance deteriorates. No dilution pressure is currently expected, with shares outstanding remaining unchanged between basic and diluted shares. Recent filings and transcripts do not highlight any material events or strategic shifts. The company's operations remain focused on its core housing and nursing services, with real estate investments as a secondary activity.